Skip to main content

TECH

Stock
Health Care
Biotechnology

Performance overview

TECH Price
Price Chart

Forward-looking statistics

Beta
0.71
Risk
36.21%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.

Company info

SectorHealth Care
IndustryBiotechnology
Employees2K
Market cap$12.2B

Fundamentals

Enterprise value$8.3B
Revenue$1.2B
Revenue per employee—
Profit margin10.89%
Debt to equity20.99

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$0.83
Dividend per share$0.32
Revenue per share$7.65
Avg trading volume (30 day)$126M
Avg trading volume (10 day)$110M
Put-call ratio—

Macro factor sensitivity

Growth+1.7
Credit+3.3
Liquidity-0.6
Inflation-1.4
Commodities+1.1
Interest Rates-1.7

Valuation

Dividend yield0.62%
PEG Ratio24.26
Price to sales6.89
P/E Ratio24.26
Enterprise Value to Revenue6.91
Price to book4.13

Upcoming events

Next earnings dayMay 7, 2025
Next dividend day—
Ex. dividend dayMay 19, 2025

News

Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock

TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.

Zacks Investment Research (June 30, 2025)
Why Is Techne (TECH) Down 3% Since Last Earnings Report?

Techne (TECH) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research (June 6, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free